[1] |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(1):7-30.
|
[2] |
Williams JL, Chan CK, Toste PA, et al. Association of histopathologic phenotype of periampullary adenocarcinomas with survival[J]. JAMA Surg, 2017, 152(1):82-88.
|
[3] |
赵静, 宋彬. 壶腹周围癌影像学诊断方法的研究现状与进展[J]. 中国普外基础与临床杂志, 2022, 29(2):239-242.
|
[4] |
Radojkovic M, Stojanovic M, Radojković D, et al. Histopathologic differentiation as a prognostic factor in patients with carcinoma of the hepatopancreatic ampulla of Vater[J]. J Int Med Res, 2018, 46(11): 4634-4639.
|
[5] |
Acharya A, Markar SR, Sodergren MH, et al. Meta-analysis of adjuvant therapy following curative surgery for periampullary adenocarcinoma[J]. Br J Surg, 2017, 104(7):814-822.
|
[6] |
祝琼洁, 张冰, 黎琪, 等. MRI术前鉴别诊断肠型和胰胆管型壶腹周围癌的价值研究[J]. 南京医科大学学报(自然科学版), 2021, 41(6):892-898.
|
[7] |
Baghmar S, Agrawal N, Kumar G, et al. Prognostic factors and the role of adjuvant treatment in periampullary carcinoma: a single-centre experience of 95 patients[J]. J Gastrointest Cancer, 2019, 50(3):361-369.
|
[8] |
Manohar KM, Sasikala M, Anuradha S, et al. MUC1, CK20, and CDX2 immunohistochemical markers can sub-classify periampullary carcinomas into pancreaticobiliary, intestinal, and mixed subtypes[J]. Indian J Pathol Microbiol, 2021, 64(4):693-701.
|
[9] |
Sree UD, Prayaga AK, R Reddy VV, et al. Differential expression of CK7, CK20, CDX2 in intestinal and pancreatobiliary types of preriampullary carcinoma[J]. Indian J Pathol Microbiol, 2022, 65(1): 42-48.
|
[10] |
van Roessel S, Soer EC, Daamen LA, et al. Preoperative misdiagnosis of pancreatic and periampullary cancer in patients undergoing pancreatoduodenectomy: a multicentre retrospective cohort study[J]. Eur J Surg Oncol, 2021, 47(10):2525-2532.
|
[11] |
Dang C, Wang M, Zhu F, et al. Comparison of laparoscopic and open pancreaticoduodenectomy for the treatment of nonpancreatic periampullary adenocarcinomas: a propensity score matching analysis[J]. Am J Surg, 2021, 222(2):377-382.
|
[12] |
Bi L, Dong Y, Jing C, et al. Differentiation of pancreatobiliary-type from intestinal-type periampullary carcinomas using 3.0T MRI[J].J Magn Reson Imaging, 2016, 43(4):877-886.
|
[13] |
Duan Z, Zhang Y, Tang Y, et al. Adjuvant therapy for periampullary carcinoma and the significance of histopathological typing: a systematic review[J]. Transl Oncol, 2022(20):101414.
|
[14] |
Komine R, Kojima M, Ishi G, et al. Recognition and pathological features of periampullary region adenocarcinoma with an indeterminable origin[J]. Cancer Med, 2021, 10(11):3499-3510.
|
[15] |
Hank T, Klaiber U, Sahora K, et al. Surgery for periampullary pancreatic cancer[J]. Chirurg, 2021, 92(9):776-787.
|
[16] |
Tang Y, Zheng Y, Chen X, et al. Identifying periampullary regions in MRI images using deep learning[J]. Front Oncol, 2021(11):674579.
|
[17] |
Poruk KE, Gay DZ, Brown K, et al. The clinical utility of CA19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates[J]. Curr Mol Med, 2013, 13(3):340-351.
|
[18] |
曹洪滔. 合并梗阻性黄疸的壶腹周围癌患者术前减黄的回顾性临床对照研究[D]. 北京: 中国医学科学院, 2021.
|
[19] |
Peng X, Jiao X, Zhao P, et al. Influence of non-jaundice stage at diagnosis on clinicopathological features and long-term survival of patients with periampullary carcinomas[J]. Medicine, 2019, 98(45): e17673.
|
[20] |
Schmuck RB, Brokat C, Andreou A, et al. Clinicopathological stratification and long-term follow-up of patients with periampullary carcinomas[J]. Anticancer Res, 2018, 38(9):5379-5386.
|